Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
...
Health Technology » Pharmaceuticals Other
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| MDCO | The Medicines Co. | -0.05% | 84.03 | 20.1% | $620.21m | |
| AMRN | Amarin Corp. Plc | 0.65% | 23.14 | 1.7% | $276.77m | |
| VRX | Valeant Pharmaceuticals International, Inc. | 8.71% | 31.89 | 14.1% | $187.65m | |
| ARQL | ArQule, Inc. | -1.04% | 19.99 | 0.6% | $140.34m | |
| SAGE | SAGE Therapeutics, Inc. | 4.70% | 76.00 | 8.6% | $135.29m | |
| BHC | Bausch Health Cos., Inc. | 8.71% | 31.89 | 0.0% | $132.19m | |
| ICPT | Intercept Pharmaceuticals, Inc. | -2.87% | 115.93 | 16.9% | $94.12m | |
| JAZZ | Jazz Pharmaceuticals Plc | 1.20% | 149.90 | 2.3% | $91.82m | |
| GWPH | GW Pharmaceuticals Plc | 2.74% | 105.70 | 6.2% | $86.29m | |
| PRGO | Perrigo Co. Plc | 1.36% | 54.54 | 6.8% | $65.30m | |
| AXSM | Axsome Therapeutics, Inc. | 1.04% | 48.57 | 2.0% | $60.26m | |
| HZNP | Horizon Therapeutics Plc | 1.83% | 32.84 | 6.6% | $44.72m | |
| ICLR | ICON plc | -0.10% | 161.57 | 4.2% | $42.46m | |
| UTHR | United Therapeutics Corp. | 1.37% | 93.76 | 14.3% | $36.17m | |
| ENDP | Endo International Plc | 7.06% | 4.70 | 8.8% | $33.53m |
Company Profile
Galmed Pharmaceuticals Ltd. is a clinical-stage biopharmaceutical company. It focuses on the development of the liver targeted stearoyl-coenzyme A desaturase-1 modulator Aramchol, novel, once-daily, oral therapy for the treatment of NASH for variable populations, as well as other liver associated disorders. The Aramchol is a synthetic conjugate of cholic acid, or a type of bile acid, and arachidic acid, or a type of saturated fatty acid, both of which, in their non-synthetic forms, are naturally occurring. The company was founded by Allen Baharaff and Tuvia Gilat in 2000 and is headquartered in Tel Aviv, Israel.